Hospitalized children with pneumonia in Uruguay: Pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program

Vaccine

Volumn 30, Issue 33, 2012, Pages 4934-4938

  Hortal, María ^a   Estevan, Miguel ^b   Laurani, Hilda ^c   Iraola, Inés ^d   Meny, Miguel ^c   Arreisengor, E ^c   Martinez, L ^c   Herman, R ^c   Bueno, S ^c   Lapides, C ^c   Lics, G ^c   Barrios, R ^c   Dornell, T ^c   Mesa, M ^c   Alves, ^c   Lic, C ^c   Fernandez, ^c   Tecn, M ^c   Finozzi, ^c   Juanicotena, S ^c  

^a PNUD/National University   (Uruguay)

^b Children's Hospital   (Uruguay)

^c Soriano 832 ^*

^d Social Security   (Uruguay)

Author keywords

Conjugate vaccine; Pleural effusion; Pneumococcal infections; Pneumonia; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; URUGUAY;

CHILD, HOSPITALIZED; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RADIOGRAPHY, THORACIC; STREPTOCOCCUS PNEUMONIAE; URUGUAY;

EID: 84862772626     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.054     Document Type: Article

References (25)

1. World Health Organization Pneumonia Vaccine Trial Investigators' Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva: Dept. of Vaccines and Biologicals, OMS; 2001.
2. Hortal M., Estevan M., Iraola I., De Mucio B. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age. Int J Infect Dis 2007, 11:273-277.
3. Rubio I. Neumonias neumococcicas: características clínicas y evolutivas de pacientes internados en el Hospital de Niños. Avances multidisciplinarios para el control integral de S. pneumoniae 2004, 51-64. OPS, Montevideo. M. Hortal, I. Iraola, T. Camou (Eds.).
4. Camou T., Palacio R., Di Fabio J.L., Hortal M. Invasive pneumococal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations. Vaccine 2003, 21:2093-2096.
5. Uruguay Ministerio de Salud Pública. Direccion General de Salud. Division Epidemiología. Campaña de nivelación con vacuna conjugada 13-valente. Montevideo: MSP; 2010. Obtenido de: . http://www/msp.gub.uy.
6. Goldblatt D., Southern J., Ashton L., Andrews N., Woodgate S., Burbidge P., et al. Immunogenicity of reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom. Pediatr Infect Dis J 2010, 29:401-405.
7. Deceuninck G., De Wals P., Boulianne N., De Serres G. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada. Pediatr Infect Dis J 2010, 29:546-549.
8. Morbidity, Mortality Weekly Report. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine - United States, 1997-2006, vol. 56. CDC, MMWR; January 16, 2009. p. 1-4.
9. Watson M., Gilmour R., Menzies R., Ferson M., McIntyre P. The association of respiratory viruses, temperature and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clin Infect Dis 2006, 42:211-215. for the New South Wales Pneumococcal Network.
10. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10:811-813. Vaccine Trialist Group.
11. Hortal M., Arbiza J.R. Pneumococcal and influenza vaccines: a synergistic effect?. Pediatr Infect Dis J 2007, 26:969. [letter].
12. Organización Panamericana de la Salud. Vigilancia Sanitaria, Prevencion y Control de Enfermedades (HSD) Informe Regional de SIREVA II. Washington, DC: OPS; 2011.
13. Hortal M., Sehabiague G., Camou T., Iraola I., Estevan M., Pujadas M. Pneumococal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations. J Pediatr 2008, 152:550-553.
14. Hausdorff W.P. The roles of pneumococcal serotypes 1 and 5 in pediatric invasive disease. Vaccine 2007, 25:2406-2412.
15. Paradiso P.R. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Clin Infect Dis 2011, 52:1241-1247.
16. Eastham K.M., Freeman R., Kearns A.M., Eltringham G., Clark J., Leeming J., et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004, 59:522-525.
17. Obando I., Muñoz-Almagro C., Arroyo L.A., Tarrgo D., Sanchez-Tatay D., Moreno-perez D., et al. Pediatric parapneumonia empyema, Spain. Emerg Infect Dis 2006, 14:1380-1387.
18. Li S.t., Tancredi D.J. Empyema hospitalizations increased in US children despite pneumococal conjugate vaccine. Pediatrics 2011, 125:26-33.
19. Muñoz-Almagro C., Jordan I., Gewne A., Latorre C., García-García J.J., Pallares R. Emergence of invasive pneumococal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2006, 46:174-186.
20. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J 2005, 24:17-23.
21. Schultz K.D., Fan L.L., Pinsky J., Ochoa L., O'Brain Smith E., Kaplan S.L., et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2011, 113:1735-1740.
22. Hausdorff W.F., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005, 5:83-93.
23. Romney M.G., Hull M.W., Gustafson R., Sanhu J., Champagne S., Wong T., et al. Large community outbreak of Streptococcus pneumoniae 5 invasive infection in an impoverished, urban population. Clin Infect Dis 2008, 47:768-774.
24. Huebner R.E., Mbelle N., Forrest B., Madore D.V., Klugman K.P. Immunogenicity after one, two and three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococal conjugate vaccine in infants in Soweto, South Africa. Pediatr Infect Dis J 2002, 21:1004-1007.
25. Silfverdal S.A., Hogh B., Bergsaker M.R., Sherlikova H., Lommel P., Borys D., et al. Immunogenicity of 2-dosepriming and boostervaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine. Pediatr Infect Dis J 2009, 28:e276-e282.